MS
The startup develops a healthcare platform that utilizes WeResp for lung morphology analysis and DigiScan for physiological modeling and AI-driven analytics. This technology enables the simulation of alternative therapies for cardiorespiratory disorders, providing patients with personalized treatment plans based on accurate data.
Updated 1 month ago
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a healthcare platform that utilizes WeResp for lung morphology analysis and DigiScan for physiological modeling and AI-driven analytics. This technology enables the simulation of alternative therapies for cardiorespiratory disorders, providing patients with personalized treatment plans based on accurate data.